Interstitial Lung Disease Slide Share

download Interstitial Lung Disease Slide Share

of 18

Transcript of Interstitial Lung Disease Slide Share

  • 8/11/2019 Interstitial Lung Disease Slide Share

    1/18

    Pulmonary rehabilitation to palliativecare

    Emma Vincent

  • 8/11/2019 Interstitial Lung Disease Slide Share

    2/18

    O ILD is a group of lung disorders in whichextensive alteration occurs to both the

    alveolar and airway architecture as aresult of inflammation and fibrosis

    O The tissue around the alveoli is called

    the interstitium. In patients with ILD thetissue becomes stiff or scarred

  • 8/11/2019 Interstitial Lung Disease Slide Share

    3/18

    O Autoimmune RA, lupus, sarcoidosis,Sjogren s

    O

    Hypersensitivity pneumonitis

    dust,fungus or moldO Medications amiodarone, methotrexate,

    nitrofuranatoin, narcotic &chemotherapeutic

    O Radiation to chestO Occupational asbestos, coal dust, cottonO Others - malignancy

  • 8/11/2019 Interstitial Lung Disease Slide Share

    4/18

    O ILD can occur without a known cause idiopathic

    O Idiopathic pulmonary fibrosis (IPF) is themost common cause of this type of ILD

  • 8/11/2019 Interstitial Lung Disease Slide Share

    5/18

    O UIP-

    Usual

    honeycombO NSIP- Non-specific ground glassO AIP Rapid, diffuse damage ground

    glassO DIP now RB-ILD (Respiratory

    Bronchiolitis)-smoking relatedO LIP HIV & connective disorders,

    Sjogrens

  • 8/11/2019 Interstitial Lung Disease Slide Share

    6/18

    O HRCT always neededO CT images when taken look like snow

    splatsO BAL usually taken lymphocytesO Autoimmune group

  • 8/11/2019 Interstitial Lung Disease Slide Share

    7/18

    O Previously known as EAAO Inflammation due variety of inhaled

    foreign substance and drug inducedO Variety of appearances sometimes similar

    to IPF

  • 8/11/2019 Interstitial Lung Disease Slide Share

    8/18

  • 8/11/2019 Interstitial Lung Disease Slide Share

    9/18

    OHistoryOPhysical examinationOChest X-rayOPFTs severity, obstruction, restriction,combinationOBloodsOOxygen assessment

    OHRCT- depending upon suspected typeO6 minute walk test

  • 8/11/2019 Interstitial Lung Disease Slide Share

    10/18

    O An interstitial pattern with obstruction may

    imply: sarcoidosis, HP, combined orconstrictive bronchiolitis.

  • 8/11/2019 Interstitial Lung Disease Slide Share

    11/18

    O BAL sent for cell count, cultures andcytology

    O Less helpful with IPF

    no predictive rolefor progression or response to therapy

    O (VATS only taken in rapid

    deterioration/sudden changes)

  • 8/11/2019 Interstitial Lung Disease Slide Share

    12/18

    O Depends upon type and severity:

    O Removal of offending agentO Pirfenidone (IPF)O CorticosteroidsO OxygenO Immunosuppressants & cytotoxic agentsO Treatment of complicationsO Pulmonary rehabilitationO Lung transplant

  • 8/11/2019 Interstitial Lung Disease Slide Share

    13/18

    O Information and supportO Symptom control/emotional health

    O Supporting treatment regimesO Implementing evidence based care- NICE

    2013O Pulmonary rehabilitationO Energy conservationO Advanced life planningO Financial advice

  • 8/11/2019 Interstitial Lung Disease Slide Share

    14/18

    O Lung function and declineO OxygenO

    ExerciseO Aiding co-morbidities- physical &

    psychologicalO Smoking cessationO Hospital admissionsO ExacerbationsO The future

  • 8/11/2019 Interstitial Lung Disease Slide Share

    15/18

    O Benefits of appropriate oxygen

    assessmentO Value of MDTO Value of pulmonary rehabilitationO Symptom controlO Advance life planningO End of life care

  • 8/11/2019 Interstitial Lung Disease Slide Share

    16/18

    O Is there a particular type of ILD that is

    more responsive to pulmonaryrehabilitation than another?O Is time of diagnosis to PR referral

    relevant?

    O Exploring the value of the MDTO Role of oxygenO Advanced care planning

  • 8/11/2019 Interstitial Lung Disease Slide Share

    17/18

    O Monitor disease severity during patientsupport

    O Note rate of progressionO Observe patient preferenceO Symptom reliefO Management of co-morbitiesO Support withdrawal of therapiesO End of life care

  • 8/11/2019 Interstitial Lung Disease Slide Share

    18/18

    O ILD management is challenging and everevolving

    O Communication of care is vitalO Listening to patient fears is invaluableO The MDT builds a truer picture of patient

    needO Patient education is empowermentO Aid their death with ease of breath